Breaking News Instant updates and real-time market news.

ALNY

Alnylam

$80.00

-3.67 (-4.39%)

04:55
09/27/19
09/27
04:55
09/27/19
04:55

Alnylam management to meet with Needham

Meeting to be held in Toronto on September 27 hosted by Needham.

  • 27

    Sep

  • 02

    Oct

  • 04

    Feb

ALNY Alnylam
$80.00

-3.67 (-4.39%)

08/26/19
PIPR
08/26/19
NO CHANGE
PIPR
The Medicines Co. data a positive for Alnylam, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff reiterated an Overweight rating and $142 price target on Alnylam Pharmaceuticals (ALNY) after its partner, The Medicines Co. (MDCO), announced positive top-line data from its Phase III ORION-11 trial of inclisiran. The analyst believes inclisiran will be approved next year, and noted that Alnylam is eligible for "milestones plus up to double-digit royalties."
09/02/19
PIPR
09/02/19
NO CHANGE
Target $145
PIPR
Overweight
Alnylam price target raised to $145 from $142 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Alnylam (ALNY) to $145 from $142 after partner The Medicine Co. (MDCO) presented positive Phase III ORION-11 data on inclisiran in 1,617 ASCVD patients at the European Society of Cardiology Congress in Paris. The analyst remains confident in inclisiran approval next year and Alnylam is eligible for milestones plus up to double-digit royalties. He reiterates an Overweight rating on Alnylam shares.
09/03/19
STFL
09/03/19
NO CHANGE
Target $116
STFL
Buy
Alnylam data broadly support inclisiran as approvable drug, says Stifel
After Alnylam (ALNY) partner The Medicine Co. (MDCO) presented Phase 3 data on inclisiran at the European Society of Cardiology Congress, Stifel analyst Paul Matteis said the efficacy data were positive, but the focus is really on safety and "encouragingly" the adverse events, incidence of death, and serious adverse events all occurred at similar rates on inclisiran versus placebo. The analyst, who believes the data broadly support inclisiran as an approvable drug, also thinks the results validate Alnylam's recent efforts in non-orphan areas. Matteis, who noted that Alnylam will receive up to a 20% royalty on inclisiran sales, has a Buy rating and $116 price target on Alnylam shares.
09/10/19
PIPR
09/10/19
NO CHANGE
Target $145
PIPR
Overweight
Alnylam's updated OLE data shows reduced 'daily worst pain,' says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff reiterated an Overweight rating and $145 price target on Alnylam after the company presented new results from the Phase III ENVISION trial and Phase I/II OLE study of givosiran in Acute Hepatic Poprphyria at the International Congress on Porphyrins and Porphyrias Conference. Tenthoff says the updated OLE data showed that monthly givosiran dosing reduced median annualized attack rate to 0.22 over 30 months, and patient reported outcomes also revealed reduced "daily worst pain" for subjects receiving givosiran, lower use of opioids and improved quality of life. Tenthoff tells investors in a research note that he is "confident" in FDA approval by the February 4 PDUFA date.

TODAY'S FREE FLY STORIES

IGT

International Game

$13.15

-0.25 (-1.87%)

13:25
10/18/19
10/18
13:25
10/18/19
13:25
Options
International Game call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
10/18/19
10/18
13:25
10/18/19
13:25
General news
Wall Street is taking a hit on a couple of news items »

Wall Street is taking a…

13:25
10/18/19
10/18
13:25
10/18/19
13:25
Conference/Events
JPMorgan autos/auto parts analyst to hold an analyst/industry conference call »

Autos & Auto Parts…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
10/18/19
10/18
13:17
10/18/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
10/18/19
10/18
13:16
10/18/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GGAL

Grupo Financiero

$12.45

-0.05 (-0.40%)

13:15
10/18/19
10/18
13:15
10/18/19
13:15
Options
Grupo Financiero put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWBO

Northwest Biotherapeutics

$0.00

(0.00%)

13:12
10/18/19
10/18
13:12
10/18/19
13:12
Syndicate
Breaking Syndicate news story on Northwest Biotherapeutics »

Northwest Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BA

Boeing

$355.77

-13.36 (-3.62%)

13:12
10/18/19
10/18
13:12
10/18/19
13:12
Periodicals
Boeing pilot said he 'lied' to FAA in texts to colleague, NY Times reports »

Mark Forkner, a Boeing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

MAT

Mattel

$11.18

0.07 (0.63%)

13:06
10/18/19
10/18
13:06
10/18/19
13:06
Recommendations
Mattel analyst commentary  »

Jefferies sees increased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

13:05
10/18/19
10/18
13:05
10/18/19
13:05
General news
Baker-Hughes Rig Count N. Amer. data reported »

Week of 10/18…

FEYE

FireEye

$15.06

-0.06 (-0.40%)

13:05
10/18/19
10/18
13:05
10/18/19
13:05
Options
FireEye call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

BHGE

Baker Hughes

$0.00

(0.00%)

13:03
10/18/19
10/18
13:03
10/18/19
13:03
Hot Stocks
Baker Hughes reports U.S. rig count down 5 to 851 rigs »

Baker Hughes reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

MAT

Mattel

$11.26

0.15 (1.35%)

12:59
10/18/19
10/18
12:59
10/18/19
12:59
Periodicals
Study finds Fisher-Price Rock 'n Play 'dangerous and deadly,' CBS News says »

A study has found that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

NKE

Nike

$95.67

0.13 (0.14%)

12:55
10/18/19
10/18
12:55
10/18/19
12:55
Options
Nike put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

TRHC

Tabula Rasa HealthCare

$47.88

-3.24 (-6.34%)

12:48
10/18/19
10/18
12:48
10/18/19
12:48
Recommendations
Tabula Rasa selling off today on 'misunderstanding,' says Piper Jaffray »

Piper Jaffray analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URI

United Rentals

$128.40

0.64 (0.50%)

12:45
10/18/19
10/18
12:45
10/18/19
12:45
Options
United Rentals call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
10/18/19
10/18
12:45
10/18/19
12:45
General news
Breaking General news story  »

Week of 10/18…

TRHC

Tabula Rasa HealthCare

$47.88

-3.24 (-6.34%)

12:41
10/18/19
10/18
12:41
10/18/19
12:41
Recommendations
Tabula Rasa HealthCare analyst commentary  »

Tabula Rasa selloff on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$355.30

-13.83 (-3.75%)

12:39
10/18/19
10/18
12:39
10/18/19
12:39
Hot Stocks
Boeing falls after telling FAA employees may have misled agency on 737 safety »

The Federal Aviation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BA

Boeing

$355.30

-13.83 (-3.75%)

12:38
10/18/19
10/18
12:38
10/18/19
12:38
Periodicals
FAA says Boeing employees seem to have misled agency about 737 MAX, Reuters says »

Boeing handed over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

NOK

Nokia

$5.21

-0.025 (-0.48%)

12:35
10/18/19
10/18
12:35
10/18/19
12:35
Options
Nokia put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

ORCL

Oracle

$54.54

-0.53 (-0.96%)

12:30
10/18/19
10/18
12:30
10/18/19
12:30
Hot Stocks
Oracle confirms passing of co-CEO Mark Hurd »

Oracle CTO and cofounder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSLR

First Solar

$55.52

0.3 (0.54%)

12:25
10/18/19
10/18
12:25
10/18/19
12:25
Options
First Solar call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

RARE

Ultragenyx

$42.78

-1.06 (-2.42%)

12:25
10/18/19
10/18
12:25
10/18/19
12:25
Conference/Events
Ultragenyx participates in a conference call with JPMorgan »

Large Cap Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 31

    Jul

UBER

Uber

$31.59

-1 (-3.07%)

, LYFT

Lyft

$40.79

-0.91 (-2.18%)

12:25
10/18/19
10/18
12:25
10/18/19
12:25
Conference/Events
UBS services analyst to hold an analyst/industry conference call »

Services Analyst Wadewitz…

UBER

Uber

$31.59

-1 (-3.07%)

LYFT

Lyft

$40.79

-0.91 (-2.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 30

    Oct

  • 04

    Nov

  • 07

    Nov

  • 19

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.